Zymeworks (ZYME) Change in Taxes (2022 - 2026)
Zymeworks (ZYME) reported Change in Taxes of -$16000.0 for Q1 2026, down 1500.0% on a YoY basis from $1142.9 in Q1 2025, and up 98.29% sequentially from -$933000.0 in Q4 2025.
Zymeworks (ZYME) Change in Taxes (2022 - 2026) Analysis & Trends
Zymeworks (ZYME) has 5 years of Change in Taxes data on file, last reported at -$16000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Taxes fell 1500.0% year-over-year to -$16000.0; the trailing twelve-month figure through Mar 2026 stood at -$60000.0 (up 96.54% YoY), and the FY2025 full-year result was -$45000.0, up 97.32% from the prior year.
- Change in Taxes improved to -$16000.0 in Q1 2026, from -$933000.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $979000.0 in Q4 2023 to a low of -$1.9 million in Q4 2024.
- A 5-year average of $5153.8 and a median of $50000.0 in 2024 frame the typical range for Change in Taxes.
- Across the five-year window, Change in Taxes jumped 567.88% in 2025 and slumped 1500.0% in 2026, its largest moves.
- Tracing ZYME's Change in Taxes over 5 years: stood at $840000.0 in 2022, then increased by 16.55% to $979000.0 in 2023, then plunged by 298.47% to -$1.9 million in 2024, then jumped by 51.98% to -$933000.0 in 2025, then soared by 98.29% to -$16000.0 in 2026.
- Business Quant data shows ZYME's Change in Taxes at -$16000.0 in Q1 2026, -$933000.0 in Q4 2025, and $915000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | -16,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16,000.00 |
| Mar 31, 2026 | -16,000.00 |
| Dec 31, 2025 | -933,000.00 |
| Dec 31, 2025 | -933,000.00 |
| Sep 30, 2025 | 915,000.00 |
| Sep 30, 2025 | 915,000.00 |
| Jun 30, 2025 | -26,000.00 |
| Jun 30, 2025 | -26,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -1.94 Mn |
| Dec 31, 2024 | -1.94 Mn |
| Sep 30, 2024 | 137,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 979,000.00 |
| Dec 31, 2023 | 979,000.00 |